Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002945662 | SCV003684617 | uncertain significance | Inborn genetic diseases | 2021-11-15 | criteria provided, single submitter | clinical testing | The c.959A>G (p.Q320R) alteration is located in exon 4 (coding exon 4) of the MAP3K1 gene. This alteration results from a A to G substitution at nucleotide position 959, causing the glutamine (Q) at amino acid position 320 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003641060 | SCV004398754 | likely benign | 46,XY sex reversal 6 | 2023-10-11 | criteria provided, single submitter | clinical testing |